Condensed Consolidated Balance Sheets - USD ($) $ in Thousands	Oct. 31, 2020	Apr. 30, 2020
Current assets:
Cash and cash equivalents	$ 348,986	$ 297,081
Restricted cash	2,325	2,308
Accounts receivable, net of allowance for credit losses of $1,505 and $1,247 as of October 31, 2020 and April 30, 2020, respectively	132,523	128,690
Deferred contract acquisition costs	28,487	19,537
Prepaid expenses and other current assets	31,805	32,623
Total current assets	544,126	480,239
Property and equipment, net	8,004	7,760
Goodwill	198,196	197,877
Operating lease right-of-use assets	30,277	32,783
Intangible assets, net	43,362	50,455
Deferred contract acquisition costs, non-current	35,996	24,012
Deferred tax assets	3,685	3,164
Other assets	3,915	7,621
Total assets	867,561	803,911
Current liabilities:
Accounts payable	9,213	11,485
Accrued expenses and other liabilities	21,824	22,210
Accrued compensation and benefits	46,975	48,409
Operating lease liabilities	7,863	7,639
Deferred revenue	262,257	231,681
Total current liabilities	348,132	321,424
Deferred revenue, non-current	46,959	28,021
Operating lease liabilities, non-current	25,032	27,827
Other liabilities, non-current	4,781	12,992
Total liabilities	424,904	390,264
Commitments and contingencies (Note 7)
Shareholders’ equity:
Convertible preference shares, €0.01 par value; 165,000,000 shares authorized, 0 shares issued and outstanding as of October 31, 2020 and April 30, 2020	0	0
Ordinary shares, par value €0.01 per share: 165,000,000 shares authorized; 87,204,991 and 82,856,978 shares issued and outstanding as of October 31, 2020 and April 30, 2020, respectively	908	856
Treasury stock	(369)	(369)
Additional paid-in capital	986,075	898,788
Accumulated other comprehensive loss	(11,914)	(1,377)
Accumulated deficit	(532,043)	(484,251)
Total shareholders’ equity	442,657	413,647
Total liabilities and shareholders’ equity	$ 867,561	$ 803,911